These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1218434)

  • 1. [Antocholinergic antiparkinsonic drugs in contemporary psychiatry (author's transl)].
    Dolezalová B; Vacek J
    Cesk Psychiatr; 1975 Dec; 71(6):398-403. PubMed ID: 1218434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug induced extrapyramidal effects--a review.
    Coleman JH; Hayes PE
    Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs and indications for medical treatment in Parkinson's disease (author's transl)].
    Allain H; Van den Driessche J; Menault F; Pape D; Reymann JM; Bentue-Ferrer D
    Sem Hop; 1980 Feb 8-15; 56(5-6):277-82. PubMed ID: 6243802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J; Floreánová L; Polák L
    Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiparkinsonian drugs (author's transl)].
    Ando K
    No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacist in the care of ambulatory mental health patients.
    Ivey MF
    Am J Hosp Pharm; 1973 Jul; 30(7):599-602. PubMed ID: 4715103
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in extrapyramidal symptoms following anticholinergic drug withdrawal.
    Perenyi A; Gardos G; Samu I; Kallos M; Cole JO
    Clin Neuropharmacol; 1983 Mar; 6(1):55-61. PubMed ID: 6133613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and abuse of anticholinergic drugs in psychiatry.
    Gelenberg AJ
    Hillside J Clin Psychiatry; 1984; 6(2):148-55. PubMed ID: 6396187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J
    Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiparkinson agents].
    Staal-Schreinemachers AL; Lakke JP
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):228-30. PubMed ID: 3561558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuroleptic-antiparkinson corrector antagonism].
    Bourgeois M; Tignol J; Bouey P
    Nouv Presse Med; 1977 Feb; 6(7):564. PubMed ID: 840637
    [No Abstract]   [Full Text] [Related]  

  • 18. Use or abuse of antiparkinsonian drugs by psychiatric patients.
    Saran AS
    J Clin Psychiatry; 1986 Mar; 47(3):130-2. PubMed ID: 2869028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various encephalopathies caused by drugs].
    Uldry PA; Regli F; Naegeli C
    Schweiz Rundsch Med Prax; 1989 Jun; 78(23):658-62. PubMed ID: 2568672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unwanted effects of psychotropic drugs--selected results from a 10-year multicenter project monitoring drugs in psychiatry].
    Grohmann R; Schmidt LG; Antretter K; Rüther E
    Internist (Berl); 1990 Jul; 31(7):468-74. PubMed ID: 1975570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.